NCT07250555

Brief Summary

The aims of the study are:

  1. 1.To examine skeletal muscle and blood metabolites during an official basketball game and to relate those to skeletal muscle performance during and after the game.
  2. 2.To investigate whether skeletal muscle and blood metabolites are related to game-induced fatigue.
  3. 3.To relate field activity during a basketball game with the responses of skeletal muscle and blood metabolites.
  4. 4.To investigate how blood lactate reflects muscle lactate concentration during a basketball game.
  5. 5.To determine whether temporary fatigue develops during a basketball game. game.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 28, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 26, 2025

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

November 26, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

August 28, 2025

Last Update Submit

November 22, 2025

Conditions

Keywords

basketballperformanceblood metabolitesskeletal muscle metabolism

Outcome Measures

Primary Outcomes (12)

  • Measurement of countermovement jump height

    Will be measured using a force platform system

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Bilateral strength peak force and rate of force development on mid-thigh pull

    Will be measured using a dynamometer.

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of maximal sprinting speed over 5 meters

    5-m sprinting speed will be assessed on the basketball court using infrared photocells

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of maximal sprinting speed over 20 meters

    20-m sprinting speed will be assessed on the basketball court using infrared photocells

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of the capacity to perform repeated sprints

    5 x 20m repeated maximal sprints will be performed with 25 sec rest in between. Speed will be recorded using infrared photocells

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of field activity variables during the basketball game

    Field activity will be continuously recorded during the basketball game using a microsensor inertial measurement unit (Kinexon Perform IMU).

    Continuous monitoring during each 40-minute game.

  • Measurement of heart rate during the basketball game ad recording the average and maximal heart rate of the game.

    Field activity will be continuously recorded during the basketball game using a Team Polar Pro heart rate monitor.

    Continuous monitoring during each 40-minute game.

  • Measurement of skeletal muscle glycogen content

    Will be assessed on muscle biopsy samples. Muscle glycogen content will be determined spectrophotometrically.

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of skeletal muscle fiber-type distribution and fiber-type- specific glycogen content.

    Will be assessed on muscle biopsy samples by histochemical analysis

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of skeletal muscle phosphocreatine levels

    Will be assessed on muscle biopsy samples by a flurometric assay.

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of skeletal muscle lactate

    Will be assessed on muscle biopsy samples by a flurometric assay.

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

  • Measurement of effort and fatigue

    Will be measured by using the Borg Rating of Perceived Exertion (RPE) scale

    Change from baseline to the: a. 20th minute (half-time) and 40th minute (end of the game) (N=10), b. 5th minute (mid-1st period) and 25th minute (mid-3rd period) (N=10) and c. 15th minute (mid-2nd period) and 35th minute (mid-4th period) (N=10).

Secondary Outcomes (24)

  • Body mass

    Change from baseline (pre-game) to 40 minutes of the game

  • Body height

    At baseline

  • Body mass index (BMI)

    At baseline

  • Body fat (BF)

    At baseline

  • Fat mass (FM)

    At baseline

  • +19 more secondary outcomes

Study Arms (1)

BASKETBALL GROUP

EXPERIMENTAL
Other: BASKETBALL GAME

Interventions

Participants will arrive 1.5 hours pre-game for initial vastus lateralis muscle biopsies and blood sampling under local anesthesia (20 mg/ml xylocaine without adrenalin). They will be fitted with IMU sensors and heart rate monitors. Volunteers are randomly assigned to teams(6 teams) for a full 40-minute game. During the match, physiological measurements will be performed at fixed times (pre, at half-time, and post-match) and after intense exercise periods (HR\>90% max, high-speed runs\>18km/h) within the four 10-min periods. Three groups provide samples: Group 1 (n=15): rest, half-time, end-game. Group 2 (n=8): rest, post-intense period in 1st/3rd periods. Group 3 (n=7): rest, post-intense period in 2nd/4th periods. Ten players serve as substitutes. Games will start at 17.00 - 18 p.m. to avoid diurnal variations and will be held under normal environmental conditions. A standardized 30-min warm-up period will be performed before each game.

BASKETBALL GROUP

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Health status: were free of recent musculoskeletal injuries and/or illnesses (≥ 8 months before the study).
  • Not consuming ergogenic supplements/medications (≥ 6 months before the study)
  • Not smokers

You may not qualify if:

  • Completion of the pre-determined participation time during the experimental game.
  • Completion of all field measurements.
  • Completion of all pre-determined sampling points for biological tissue.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Thessaly, Department of Physical Education and Sports Science

Trikala, Thessaly, 42100, Greece

RECRUITING

Central Study Contacts

Ioannis G Fatouros, Professor

CONTACT

Athanasios Chatzinicolaou, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 28, 2025

First Posted

November 26, 2025

Study Start

May 30, 2025

Primary Completion

November 30, 2025

Study Completion

February 28, 2026

Last Updated

November 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations